Trials / Conditions / Acute Bacterial Skin and Skin Structure Infection

Acute Bacterial Skin and Skin Structure Infection

6 registered clinical trials studyying Acute Bacterial Skin and Skin Structure Infection.

Status	Trial	Sponsor	Phase
Completed	Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections NCT05599295	Melinta Therapeutics, LLC	Phase 2
Completed	Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With NCT04298463	Aziende Chimiche Riunite Angelini Francesco S.p.A	—
Unknown	Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized P NCT04229511	SCARE (Study group for carbapenem resistance)	—
Completed	Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients NCT03873987	Melinta Therapeutics, Inc.	Phase 1
Completed	Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABS NCT03233438	Allergan	Phase 4
Completed	A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on NCT02452918	The Medicines Company	Phase 4